Professor Dame Anna Dominiczak
Regius Professor of Medicine, Vice Principal and Head of College of Medical, Veterinary and Life Sciences
‘At the University of Glasgow, we continue to champion the importance of a precision medicine approach to health care where research and industry collaborators work closely together. We are proud to house the Stratified Medicine Scotland Innovation Centre, an area that has been purpose built to bring world-leading research and innovative industry together.’
Vice-Principal and Head of College of Medical, Veterinary & Life Sciences
Professor Dame Anna Dominiczak, DBE, MD, FRCP, FAHA, FRSE, FMedSci, is Regius Professor of Medicine, Vice Principal and Head of the College of Medical, Veterinary and Life Sciences at the University of Glasgow; Honorary Consultant Physician and Non-Executive Member of NHS Greater Glasgow and Clyde Health Board; and Health Innovation Champion for the Medical Research Council. In 2016, she was awarded a DBE for services to cardiovascular and medical science.
Recognised as a world-leading cardiovascular scientist and clinical academic, she held a British Heart Foundation Chair of Cardiovascular Medicine at University of Glasgow between 1997 and 2010, and directorship of the Cardiovascular Research Centre between 2000 and 2010. Her major research interests are in hypertension, cardiovascular genomics and precision medicine, where she not only publishes extensively in top peer-reviewed journals (over 400 publications), but also excels in large scale research funding for programmes and infrastructure (with a total value in excess of £100M over the last seven years).
Professor Dominiczak is the driving force behind the fundraising, development and delivery of the University’s clinical academic campus at Queen Elizabeth University Hospital in Glasgow, comprising Clinical Research Facilities; a Teaching and Learning Centre; a state-of-the-art Imaging Centre of Excellence (including the UK’s first 7Tesla MRI scanner in a clinical setting); and a Clinical Innovation Zone. She leads a triple helix partnership between academia, NHS and industry to accelerate innovation, maximise patient benefit and stimulate business growth, including a collaboration of four universities, four NHS Health Boards and two major industry partners in a public/private partnership focused on precision medicine, with a value in excess of £20M.
She is a Fellow of the Royal College of Physicians, the American Heart Association, the Academy of Medical Sciences, the Royal Society of Edinburgh, the European Society of Cardiology and the Society of Biology. She is a member of the British Medical Association, the British Hypertension Society, the European Society of Hypertension, the International Society of Hypertension, the British Endocrine Society, the Association of Physicians of Great Britain and Ireland, the American Physiological Society, the British Atherosclerosis Society, the British Cardiovascular Society and the European Atherosclerosis Society. From 2013 to 2015, she was President of the European Society of Hypertension.
Professor Dominiczak has served extensively on national and international research committees and advisory boards, including those of the Academy of Medical Sciences and the Royal Society of Edinburgh. She is Chair of the Medical Research Council’s Translational Research Group and the Equality and Diversity Working Group of the Medical, Dental and Veterinary Schools Councils. She is a member of the Medical Research Council’s Strategy Board, the Medical Schools Council’s Executive and the Academy of Medical Sciences’ Council. She is also a Trustee of British Heart Foundation.
She has been invited to give over 100 international plenary lectures, including the Presidential Award and Lecture of the Canadian Hypertension Society, the Arthur Corcoran Award and Lecture of the American Heart Association, the R.D. Wright Award and Lecture of the High Blood Pressure Research Council of Australia, the Bjorn Folkow Award and Lecture of the European Society of Hypertension, the Sackler Fellowship and Lecture, the William Harvey Outstanding Contribution to Science Award and Lecture, the Robert Tigerstedt Award and Lecture, and, in 2017, the British Hypertension Society’s Pickering Lecture.
In addition to membership of several editorial boards, since 2012, Professor Dominiczak has been Editor-in-Chief of Hypertension, journal of the American Heart Association and the world’s top journal in her area of research.